Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
20001
20002
20003
20004
20005
20006
20007
20008
20009
20010
20011
20012
20013
20014
20015
20016
20017
20018
20019
20020
20021
20022
20023
20024
20025
20026
20027
20028
20029
20030
20031
20032
20033
20034
20035
20036
20037
20038
20039
20040
20041
20042
20043
20044
20045
20046
20047
20048
20049
20050
20051
20052
20053
20054
20055
20056
20057
20058
20059
20060
20061
20062
20063
20064
20065
20066
20067
20068
20069
20070
20071
20072
20073
20074
20075
20076
20077
20078
20079
20080
20081
20082
20083
20084
20085
20086
20087
20088
20089
20090
20091
20092
20093
20094
20095
20096
20097
20098
20099
20100
20101
20102
20103
20104
20105
20106
20107
20108
20109
20110
20111
20112
20113
20114
20115
20116
20117
20118
20119
20120
20121
20122
20123
20124
20125
20126
20127
20128
20129
20130
20131
20132
20133
20134
20135
20136
20137
20138
20139
20140
20141
20142
20143
20144
20145
20146
20147
20148
20149
20150
20151
20152
20153
20154
20155
20156
20157
20158
20159
20160
20161
20162
20163
20164
20165
20166
20167
20168
20169
20170
20171
20172
20173
20174
20175
20176
20177
20178
20179
20180
20181
20182
20183
20184
20185
20186
20187
20188
20189
20190
20191
20192
20193
20194
20195
20196
20197
20198
20199
20200
| UnnamedSample_HQ_transcript/62021|m.16452 | UnnamedSample_HQ_transcript/62021 | Coverage 0.756 too low. | ab4280b1282f7b4bc6fac9f120cf477f | 493 | Pfam | PF13771 | PHD-like zinc-binding domain | 42 | 129 | 1.7E-17 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/13595|m.4982 | UnnamedSample_HQ_transcript/13595 | Coverage 0.181 too low. | 6c847c3159a0b904f0d96219d07d1d3d | 1074 | Pfam | PF08264 | Anticodon-binding domain of tRNA ligase | 686 | 807 | 4.0E-14 | T | 22-09-2020 | IPR013155 | Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding |
| UnnamedSample_HQ_transcript/13595|m.4982 | UnnamedSample_HQ_transcript/13595 | Coverage 0.181 too low. | 6c847c3159a0b904f0d96219d07d1d3d | 1074 | Pfam | PF00133 | tRNA synthetases class I (I, L, M and V) | 80 | 646 | 6.3E-28 | T | 22-09-2020 | IPR002300 | Aminoacyl-tRNA synthetase, class Ia |
| UnnamedSample_HQ_transcript/97188|m.22260 | UnnamedSample_HQ_transcript/97188 | Coverage 0.960 too low. | 6b6cd4f9ef2960d8d8d0e5516f312221 | 344 | Pfam | PF15277 | Exocyst complex component SEC3 N-terminal PIP2 binding PH | 33 | 121 | 1.1E-22 | T | 22-09-2020 | IPR028258 | Exocyst complex component Sec3, PIP2-binding N-terminal domain |
| UnnamedSample_HQ_transcript/97188|m.22260 | UnnamedSample_HQ_transcript/97188 | Coverage 0.960 too low. | 6b6cd4f9ef2960d8d8d0e5516f312221 | 344 | Pfam | PF09763 | Exocyst complex component Sec3 | 196 | 344 | 9.2E-26 | T | 22-09-2020 | IPR019160 | Exocyst complex component Sec3, C-terminal |
| UnnamedSample_HQ_transcript/104792|m.23206 | UnnamedSample_HQ_transcript/104792 | Coverage 0.224 too low. | a5cbe236a5f850bde5447aff26537541 | 274 | Pfam | PF11788 | 39S mitochondrial ribosomal protein L46 | 33 | 131 | 1.0E-10 | T | 22-09-2020 | IPR021757 | Ribosomal protein L46, N-terminal |
| UnnamedSample_HQ_transcript/28088|m.8992 | UnnamedSample_HQ_transcript/28088 | Coverage 0.592 too low. | 29c720edf5e1bfc913ae2c0a1de340db | 677 | Pfam | PF02437 | SKI/SNO/DAC family | 127 | 232 | 2.6E-38 | T | 22-09-2020 | IPR003380 | SKI/SNO/DAC domain |
| UnnamedSample_HQ_transcript/8424|m.3330 | UnnamedSample_HQ_transcript/8424 | Coverage 0.911 too low. | 469eb6960ab88fd9eef56b049a03fff0 | 845 | Pfam | PF00041 | Fibronectin type III domain | 625 | 709 | 9.0E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/8424|m.3330 | UnnamedSample_HQ_transcript/8424 | Coverage 0.911 too low. | 469eb6960ab88fd9eef56b049a03fff0 | 845 | Pfam | PF00041 | Fibronectin type III domain | 508 | 591 | 7.9E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/8424|m.3330 | UnnamedSample_HQ_transcript/8424 | Coverage 0.911 too low. | 469eb6960ab88fd9eef56b049a03fff0 | 845 | Pfam | PF13927 | Immunoglobulin domain | 425 | 489 | 2.6E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8424|m.3330 | UnnamedSample_HQ_transcript/8424 | Coverage 0.911 too low. | 469eb6960ab88fd9eef56b049a03fff0 | 845 | Pfam | PF13927 | Immunoglobulin domain | 26 | 111 | 1.9E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8424|m.3330 | UnnamedSample_HQ_transcript/8424 | Coverage 0.911 too low. | 469eb6960ab88fd9eef56b049a03fff0 | 845 | Pfam | PF13927 | Immunoglobulin domain | 220 | 290 | 3.0E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8424|m.3330 | UnnamedSample_HQ_transcript/8424 | Coverage 0.911 too low. | 469eb6960ab88fd9eef56b049a03fff0 | 845 | Pfam | PF07679 | Immunoglobulin I-set domain | 313 | 406 | 3.7E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/8424|m.3330 | UnnamedSample_HQ_transcript/8424 | Coverage 0.911 too low. | 469eb6960ab88fd9eef56b049a03fff0 | 845 | Pfam | PF07679 | Immunoglobulin I-set domain | 131 | 212 | 1.1E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/96358|m.22149 | UnnamedSample_HQ_transcript/96358 | Coverage 0.987 too low. | 4115433d2119ea056261ebf440c62ff6 | 208 | Pfam | PF17809 | UPA domain | 78 | 192 | 4.4E-47 | T | 22-09-2020 | IPR040745 | Ankyrin, UPA domain |
| UnnamedSample_HQ_transcript/50911|m.14229 | UnnamedSample_HQ_transcript/50911 | Coverage 0.098 too low. | d3c63668539ce1dca2cccabea556ad88 | 629 | Pfam | PF00027 | Cyclic nucleotide-binding domain | 481 | 568 | 7.4E-20 | T | 22-09-2020 | IPR000595 | Cyclic nucleotide-binding domain |
| UnnamedSample_HQ_transcript/66165|m.17243 | UnnamedSample_HQ_transcript/66165 | Coverage 0.897 too low. | b1b7b921a2394b22ecb163077322f51e | 258 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 12 | 228 | 2.7E-46 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/82602|m.20134 | UnnamedSample_HQ_transcript/82602 | Identity 0.574 too low. | fe1c3a6dfba588e7662af008fee8594f | 198 | Pfam | PF00412 | LIM domain | 140 | 190 | 1.2E-12 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/82602|m.20134 | UnnamedSample_HQ_transcript/82602 | Identity 0.574 too low. | fe1c3a6dfba588e7662af008fee8594f | 198 | Pfam | PF00412 | LIM domain | 81 | 136 | 3.2E-17 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/82602|m.20134 | UnnamedSample_HQ_transcript/82602 | Identity 0.574 too low. | fe1c3a6dfba588e7662af008fee8594f | 198 | Pfam | PF00412 | LIM domain | 22 | 76 | 6.2E-18 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/78883|m.19531 | UnnamedSample_HQ_transcript/78883 | Identity 0.623 too low. | fe1c3a6dfba588e7662af008fee8594f | 198 | Pfam | PF00412 | LIM domain | 140 | 190 | 1.2E-12 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/78883|m.19531 | UnnamedSample_HQ_transcript/78883 | Identity 0.623 too low. | fe1c3a6dfba588e7662af008fee8594f | 198 | Pfam | PF00412 | LIM domain | 81 | 136 | 3.2E-17 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/78883|m.19531 | UnnamedSample_HQ_transcript/78883 | Identity 0.623 too low. | fe1c3a6dfba588e7662af008fee8594f | 198 | Pfam | PF00412 | LIM domain | 22 | 76 | 6.2E-18 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/64551|m.16954 | UnnamedSample_HQ_transcript/64551 | Identity 0.680 too low. | fe1c3a6dfba588e7662af008fee8594f | 198 | Pfam | PF00412 | LIM domain | 140 | 190 | 1.2E-12 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/64551|m.16954 | UnnamedSample_HQ_transcript/64551 | Identity 0.680 too low. | fe1c3a6dfba588e7662af008fee8594f | 198 | Pfam | PF00412 | LIM domain | 81 | 136 | 3.2E-17 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/64551|m.16954 | UnnamedSample_HQ_transcript/64551 | Identity 0.680 too low. | fe1c3a6dfba588e7662af008fee8594f | 198 | Pfam | PF00412 | LIM domain | 22 | 76 | 6.2E-18 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/574|m.421 | UnnamedSample_HQ_transcript/574 | Coverage 0.043 too low. | 9457eb51e982f0b30a4fdc052355509d | 1150 | Pfam | PF14598 | PAS domain | 307 | 416 | 8.3E-32 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/77892|m.19355 | UnnamedSample_HQ_transcript/77892 | Coverage 0.814 too low. | 104d42207d6e11dd7634861d8f7d7e40 | 435 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/77892|m.19355 | UnnamedSample_HQ_transcript/77892 | Coverage 0.814 too low. | 104d42207d6e11dd7634861d8f7d7e40 | 435 | Pfam | PF16622 | zinc-finger C2H2-type | 407 | 430 | 2.1E-6 | T | 22-09-2020 | IPR041697 | Zinc-finger C2H2-type 11 |
| UnnamedSample_HQ_transcript/16640|m.5901 | UnnamedSample_HQ_transcript/16640 | Identity 0.912 too low. | c774a42494f5b0486f38cb3df646d92a | 1017 | Pfam | PF00400 | WD domain, G-beta repeat | 248 | 285 | 4.5E-4 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/81565|m.19963 | UnnamedSample_HQ_transcript/81565 | Coverage 0.697 too low. | 825364b2283ab2da3b255f13865bd7b6 | 322 | Pfam | PF18701 | Family of unknown function (DUF5641) | 220 | 313 | 2.7E-34 | T | 22-09-2020 | IPR040676 | Domain of unknown function DUF5641 |
| UnnamedSample_HQ_transcript/47716|m.13514 | UnnamedSample_HQ_transcript/47716 | Coverage 0.822 too low. | 94e81bea03b96c6461934bdc678abe0c | 492 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 156 | 206 | 5.0E-13 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/16309|m.5798 | UnnamedSample_HQ_transcript/16309 | Identity 0.734 too low. | 09c9652c22d996b5320fba26723bb38c | 365 | Pfam | PF00696 | Amino acid kinase family | 1 | 78 | 9.7E-14 | T | 22-09-2020 | IPR001048 | Aspartate/glutamate/uridylate kinase |
| UnnamedSample_HQ_transcript/16309|m.5798 | UnnamedSample_HQ_transcript/16309 | Identity 0.734 too low. | 09c9652c22d996b5320fba26723bb38c | 365 | Pfam | PF00171 | Aldehyde dehydrogenase family | 105 | 354 | 4.0E-8 | T | 22-09-2020 | IPR015590 | Aldehyde dehydrogenase domain |
| UnnamedSample_HQ_transcript/102643|m.22944 | UnnamedSample_HQ_transcript/102643 | Coverage 0.988 too low. | dd84a64bf4072b7fa22a5b1009e01776 | 252 | Pfam | PF00650 | CRAL/TRIO domain | 101 | 240 | 2.4E-22 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/109895|m.23818 | UnnamedSample_HQ_transcript/109895 | Coverage 0.987 too low. | dd84a64bf4072b7fa22a5b1009e01776 | 252 | Pfam | PF00650 | CRAL/TRIO domain | 101 | 240 | 2.4E-22 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/108530|m.23649 | UnnamedSample_HQ_transcript/108530 | Coverage 0.986 too low. | dd84a64bf4072b7fa22a5b1009e01776 | 252 | Pfam | PF00650 | CRAL/TRIO domain | 101 | 240 | 2.4E-22 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/81311|m.19937 | UnnamedSample_HQ_transcript/81311 | Coverage 0.467 too low. | 43ebee384c266b9a0e1936e2f404f823 | 416 | Pfam | PF00170 | bZIP transcription factor | 301 | 352 | 1.7E-11 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/4925|m.2162 | UnnamedSample_HQ_transcript/4925 | Identity 0.616 too low. | 68078d858c11cd1d7ae7d0bf21e87d92 | 1175 | Pfam | PF16454 | Phosphatidylinositol 3-kinase regulatory subunit P85 inter-SH2 domain | 874 | 1033 | 9.5E-48 | T | 22-09-2020 | IPR032498 | PI3K p85 subunit, inter-SH2 domain |
| UnnamedSample_HQ_transcript/4925|m.2162 | UnnamedSample_HQ_transcript/4925 | Identity 0.616 too low. | 68078d858c11cd1d7ae7d0bf21e87d92 | 1175 | Pfam | PF00017 | SH2 domain | 776 | 850 | 5.4E-17 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/4925|m.2162 | UnnamedSample_HQ_transcript/4925 | Identity 0.616 too low. | 68078d858c11cd1d7ae7d0bf21e87d92 | 1175 | Pfam | PF00017 | SH2 domain | 1057 | 1130 | 6.1E-16 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/4925|m.2162 | UnnamedSample_HQ_transcript/4925 | Identity 0.616 too low. | 68078d858c11cd1d7ae7d0bf21e87d92 | 1175 | Pfam | PF00620 | RhoGAP domain | 547 | 673 | 5.3E-22 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/4925|m.2162 | UnnamedSample_HQ_transcript/4925 | Identity 0.616 too low. | 68078d858c11cd1d7ae7d0bf21e87d92 | 1175 | Pfam | PF07647 | SAM domain (Sterile alpha motif) | 374 | 434 | 2.9E-13 | T | 22-09-2020 | IPR001660 | Sterile alpha motif domain |
| UnnamedSample_HQ_transcript/5325|m.2310 | UnnamedSample_HQ_transcript/5325 | Identity 0.607 too low. | 68078d858c11cd1d7ae7d0bf21e87d92 | 1175 | Pfam | PF16454 | Phosphatidylinositol 3-kinase regulatory subunit P85 inter-SH2 domain | 874 | 1033 | 9.5E-48 | T | 22-09-2020 | IPR032498 | PI3K p85 subunit, inter-SH2 domain |
| UnnamedSample_HQ_transcript/5325|m.2310 | UnnamedSample_HQ_transcript/5325 | Identity 0.607 too low. | 68078d858c11cd1d7ae7d0bf21e87d92 | 1175 | Pfam | PF00017 | SH2 domain | 776 | 850 | 5.4E-17 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/5325|m.2310 | UnnamedSample_HQ_transcript/5325 | Identity 0.607 too low. | 68078d858c11cd1d7ae7d0bf21e87d92 | 1175 | Pfam | PF00017 | SH2 domain | 1057 | 1130 | 6.1E-16 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/5325|m.2310 | UnnamedSample_HQ_transcript/5325 | Identity 0.607 too low. | 68078d858c11cd1d7ae7d0bf21e87d92 | 1175 | Pfam | PF00620 | RhoGAP domain | 547 | 673 | 5.3E-22 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/5325|m.2310 | UnnamedSample_HQ_transcript/5325 | Identity 0.607 too low. | 68078d858c11cd1d7ae7d0bf21e87d92 | 1175 | Pfam | PF07647 | SAM domain (Sterile alpha motif) | 374 | 434 | 2.9E-13 | T | 22-09-2020 | IPR001660 | Sterile alpha motif domain |
| UnnamedSample_HQ_transcript/66208|m.17252 | UnnamedSample_HQ_transcript/66208 | Coverage 0.368 too low. | 3d28426abc6725c733e357b01a31a73b | 256 | Pfam | PF18100 | Phosphodiesterase 4 upstream conserved regions (UCR) | 112 | 230 | 2.0E-54 | T | 22-09-2020 | IPR040844 | Phosphodiesterase 4 upstream conserved regions (UCR) |
| UnnamedSample_HQ_transcript/54195|m.14873 | UnnamedSample_HQ_transcript/54195 | Coverage 0.774 too low. | 8d0bd15b1b2deb4e2d49a61b296b65be | 393 | Pfam | PF03250 | Tropomodulin | 48 | 187 | 5.8E-55 | T | 22-09-2020 | IPR004934 | Tropomodulin |
| UnnamedSample_HQ_transcript/78978|m.19541 | UnnamedSample_HQ_transcript/78978 | Coverage 0.838 too low. | 5b03c4518e194439ca1568707213e943 | 352 | Pfam | PF02862 | DDHD domain | 88 | 293 | 5.8E-50 | T | 22-09-2020 | IPR004177 | DDHD domain |
| UnnamedSample_HQ_transcript/73839|m.18619 | UnnamedSample_HQ_transcript/73839 | Coverage 0.911 too low. | 5b03c4518e194439ca1568707213e943 | 352 | Pfam | PF02862 | DDHD domain | 88 | 293 | 5.8E-50 | T | 22-09-2020 | IPR004177 | DDHD domain |
| UnnamedSample_HQ_transcript/71488|m.18206 | UnnamedSample_HQ_transcript/71488 | Coverage 0.865 too low. | 9fdc81544b069eabf8142439315544db | 392 | Pfam | PF14670 | Coagulation Factor Xa inhibitory site | 284 | 325 | 3.7E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/71488|m.18206 | UnnamedSample_HQ_transcript/71488 | Coverage 0.865 too low. | 9fdc81544b069eabf8142439315544db | 392 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 189 | 226 | 7.1E-6 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/71488|m.18206 | UnnamedSample_HQ_transcript/71488 | Coverage 0.865 too low. | 9fdc81544b069eabf8142439315544db | 392 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 146 | 184 | 2.4E-11 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/71488|m.18206 | UnnamedSample_HQ_transcript/71488 | Coverage 0.865 too low. | 9fdc81544b069eabf8142439315544db | 392 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 101 | 139 | 2.9E-8 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/71488|m.18206 | UnnamedSample_HQ_transcript/71488 | Coverage 0.865 too low. | 9fdc81544b069eabf8142439315544db | 392 | Pfam | PF00058 | Low-density lipoprotein receptor repeat class B | 58 | 98 | 3.7E-4 | T | 22-09-2020 | IPR000033 | LDLR class B repeat |
| UnnamedSample_HQ_transcript/16457|m.5844 | UnnamedSample_HQ_transcript/16457 | Coverage 0.748 too low. | 3f55f251368aca66888637bd7fd60ad6 | 1064 | Pfam | PF00412 | LIM domain | 904 | 961 | 2.3E-6 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/16457|m.5844 | UnnamedSample_HQ_transcript/16457 | Coverage 0.748 too low. | 3f55f251368aca66888637bd7fd60ad6 | 1064 | Pfam | PF00307 | Calponin homology (CH) domain | 532 | 634 | 1.4E-15 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/16457|m.5844 | UnnamedSample_HQ_transcript/16457 | Coverage 0.748 too low. | 3f55f251368aca66888637bd7fd60ad6 | 1064 | Pfam | PF00890 | FAD binding domain | 97 | 128 | 1.2E-5 | T | 22-09-2020 | IPR003953 | FAD-dependent oxidoreductase 2, FAD binding domain |
| UnnamedSample_HQ_transcript/35178|m.10751 | UnnamedSample_HQ_transcript/35178 | Coverage 0.502 too low. | d4d708562b6d01db454398fa95818c7e | 702 | Pfam | PF00041 | Fibronectin type III domain | 246 | 324 | 1.7E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/35178|m.10751 | UnnamedSample_HQ_transcript/35178 | Coverage 0.502 too low. | d4d708562b6d01db454398fa95818c7e | 702 | Pfam | PF00041 | Fibronectin type III domain | 540 | 623 | 1.5E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/35178|m.10751 | UnnamedSample_HQ_transcript/35178 | Coverage 0.502 too low. | d4d708562b6d01db454398fa95818c7e | 702 | Pfam | PF00041 | Fibronectin type III domain | 341 | 422 | 1.4E-13 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/35178|m.10751 | UnnamedSample_HQ_transcript/35178 | Coverage 0.502 too low. | d4d708562b6d01db454398fa95818c7e | 702 | Pfam | PF00041 | Fibronectin type III domain | 440 | 522 | 3.0E-13 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/35178|m.10751 | UnnamedSample_HQ_transcript/35178 | Coverage 0.502 too low. | d4d708562b6d01db454398fa95818c7e | 702 | Pfam | PF07679 | Immunoglobulin I-set domain | 57 | 143 | 1.8E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/35178|m.10751 | UnnamedSample_HQ_transcript/35178 | Coverage 0.502 too low. | d4d708562b6d01db454398fa95818c7e | 702 | Pfam | PF07679 | Immunoglobulin I-set domain | 156 | 237 | 4.7E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/54493|m.14942 | UnnamedSample_HQ_transcript/54493 | Coverage 0.291 too low. | 66ea995bd8ab60cf4f713f6be9e0b23e | 366 | Pfam | PF02142 | MGS-like domain | 16 | 129 | 4.0E-22 | T | 22-09-2020 | IPR011607 | Methylglyoxal synthase-like domain |
| UnnamedSample_HQ_transcript/54493|m.14942 | UnnamedSample_HQ_transcript/54493 | Coverage 0.291 too low. | 66ea995bd8ab60cf4f713f6be9e0b23e | 366 | Pfam | PF01808 | AICARFT/IMPCHase bienzyme | 135 | 364 | 2.4E-65 | T | 22-09-2020 | IPR002695 | Bifunctional purine biosynthesis protein PurH-like |
| UnnamedSample_HQ_transcript/77692|m.19329 | UnnamedSample_HQ_transcript/77692 | Coverage 0.914 too low. | c6aa50a79421a2df0fbe085d36c65362 | 338 | Pfam | PF03166 | MH2 domain | 141 | 314 | 2.2E-69 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/77692|m.19329 | UnnamedSample_HQ_transcript/77692 | Coverage 0.914 too low. | c6aa50a79421a2df0fbe085d36c65362 | 338 | Pfam | PF03165 | MH1 domain | 2 | 26 | 4.4E-6 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/94789|m.21923 | UnnamedSample_HQ_transcript/94789 | Identity 0.833 too low. | 329464477229266a28a6aaad146a9dbd | 315 | Pfam | PF03939 | Ribosomal protein L23, N-terminal domain | 177 | 226 | 1.8E-14 | T | 22-09-2020 | IPR005633 | Ribosomal protein L23/L25, N-terminal |
| UnnamedSample_HQ_transcript/94789|m.21923 | UnnamedSample_HQ_transcript/94789 | Identity 0.833 too low. | 329464477229266a28a6aaad146a9dbd | 315 | Pfam | PF00276 | Ribosomal protein L23 | 234 | 295 | 7.4E-16 | T | 22-09-2020 | IPR013025 | Ribosomal protein L25/L23 |
| UnnamedSample_HQ_transcript/99786|m.22605 | UnnamedSample_HQ_transcript/99786 | Identity 0.817 too low. | 329464477229266a28a6aaad146a9dbd | 315 | Pfam | PF03939 | Ribosomal protein L23, N-terminal domain | 177 | 226 | 1.8E-14 | T | 22-09-2020 | IPR005633 | Ribosomal protein L23/L25, N-terminal |
| UnnamedSample_HQ_transcript/99786|m.22605 | UnnamedSample_HQ_transcript/99786 | Identity 0.817 too low. | 329464477229266a28a6aaad146a9dbd | 315 | Pfam | PF00276 | Ribosomal protein L23 | 234 | 295 | 7.4E-16 | T | 22-09-2020 | IPR013025 | Ribosomal protein L25/L23 |
| UnnamedSample_HQ_transcript/40225|m.11890 | UnnamedSample_HQ_transcript/40225 | Coverage 0.820 too low. | 611fc8486e5fee4cadbe781260413199 | 326 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 231 | 300 | 1.3E-14 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/94483|m.21874 | UnnamedSample_HQ_transcript/94483 | Coverage 0.511 too low. | 495f6814cd068a65676d2570cc3d5808 | 309 | Pfam | PF00069 | Protein kinase domain | 25 | 289 | 3.3E-62 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/102123|m.22880 | UnnamedSample_HQ_transcript/102123 | Coverage 0.467 too low. | 495f6814cd068a65676d2570cc3d5808 | 309 | Pfam | PF00069 | Protein kinase domain | 25 | 289 | 3.3E-62 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/84620|m.20434 | UnnamedSample_HQ_transcript/84620 | Coverage 0.379 too low. | fff4dda61fd12bee5e7a766084d14c80 | 393 | Pfam | PF10607 | CTLH/CRA C-terminal to LisH motif domain | 154 | 297 | 2.0E-33 | T | 22-09-2020 | IPR024964 | CTLH/CRA C-terminal to LisH motif domain |
| UnnamedSample_HQ_transcript/84620|m.20434 | UnnamedSample_HQ_transcript/84620 | Coverage 0.379 too low. | fff4dda61fd12bee5e7a766084d14c80 | 393 | Pfam | PF13445 | RING-type zinc-finger | 337 | 377 | 1.2E-5 | T | 22-09-2020 | IPR027370 | RING-type zinc-finger, LisH dimerisation motif |
| UnnamedSample_HQ_transcript/80844|m.19848 | UnnamedSample_HQ_transcript/80844 | Coverage 0.422 too low. | fff4dda61fd12bee5e7a766084d14c80 | 393 | Pfam | PF10607 | CTLH/CRA C-terminal to LisH motif domain | 154 | 297 | 2.0E-33 | T | 22-09-2020 | IPR024964 | CTLH/CRA C-terminal to LisH motif domain |
| UnnamedSample_HQ_transcript/80844|m.19848 | UnnamedSample_HQ_transcript/80844 | Coverage 0.422 too low. | fff4dda61fd12bee5e7a766084d14c80 | 393 | Pfam | PF13445 | RING-type zinc-finger | 337 | 377 | 1.2E-5 | T | 22-09-2020 | IPR027370 | RING-type zinc-finger, LisH dimerisation motif |
| UnnamedSample_HQ_transcript/73595|m.18588 | UnnamedSample_HQ_transcript/73595 | Coverage 0.459 too low. | fff4dda61fd12bee5e7a766084d14c80 | 393 | Pfam | PF10607 | CTLH/CRA C-terminal to LisH motif domain | 154 | 297 | 2.0E-33 | T | 22-09-2020 | IPR024964 | CTLH/CRA C-terminal to LisH motif domain |
| UnnamedSample_HQ_transcript/73595|m.18588 | UnnamedSample_HQ_transcript/73595 | Coverage 0.459 too low. | fff4dda61fd12bee5e7a766084d14c80 | 393 | Pfam | PF13445 | RING-type zinc-finger | 337 | 377 | 1.2E-5 | T | 22-09-2020 | IPR027370 | RING-type zinc-finger, LisH dimerisation motif |
| UnnamedSample_HQ_transcript/12197|m.4556 | UnnamedSample_HQ_transcript/12197 | Coverage 0.062 too low. | 1f03f541441ab719a477da1b74b65c7a | 1004 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 52 | 121 | 6.1E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/12197|m.4556 | UnnamedSample_HQ_transcript/12197 | Coverage 0.062 too low. | 1f03f541441ab719a477da1b74b65c7a | 1004 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 222 | 396 | 4.1E-19 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/26325|m.8562 | UnnamedSample_HQ_transcript/26325 | Coverage 0.855 too low. | 0e4666013b28828312c59d9b3c2c6901 | 586 | Pfam | PF07690 | Major Facilitator Superfamily | 46 | 222 | 2.0E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/26325|m.8562 | UnnamedSample_HQ_transcript/26325 | Coverage 0.855 too low. | 0e4666013b28828312c59d9b3c2c6901 | 586 | Pfam | PF07690 | Major Facilitator Superfamily | 394 | 565 | 5.5E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/53530|m.14745 | UnnamedSample_HQ_transcript/53530 | Coverage 0.796 too low. | 0e4666013b28828312c59d9b3c2c6901 | 586 | Pfam | PF07690 | Major Facilitator Superfamily | 46 | 222 | 2.0E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/53530|m.14745 | UnnamedSample_HQ_transcript/53530 | Coverage 0.796 too low. | 0e4666013b28828312c59d9b3c2c6901 | 586 | Pfam | PF07690 | Major Facilitator Superfamily | 394 | 565 | 5.5E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/58474|m.15742 | UnnamedSample_HQ_transcript/58474 | Coverage 0.788 too low. | 0e4666013b28828312c59d9b3c2c6901 | 586 | Pfam | PF07690 | Major Facilitator Superfamily | 46 | 222 | 2.0E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/58474|m.15742 | UnnamedSample_HQ_transcript/58474 | Coverage 0.788 too low. | 0e4666013b28828312c59d9b3c2c6901 | 586 | Pfam | PF07690 | Major Facilitator Superfamily | 394 | 565 | 5.5E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/28816|m.9169 | UnnamedSample_HQ_transcript/28816 | Coverage 0.851 too low. | 0e4666013b28828312c59d9b3c2c6901 | 586 | Pfam | PF07690 | Major Facilitator Superfamily | 46 | 222 | 2.0E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/28816|m.9169 | UnnamedSample_HQ_transcript/28816 | Coverage 0.851 too low. | 0e4666013b28828312c59d9b3c2c6901 | 586 | Pfam | PF07690 | Major Facilitator Superfamily | 394 | 565 | 5.5E-15 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/42428|m.12357 | UnnamedSample_HQ_transcript/42428 | Coverage 0.876 too low. | 049c94610d9a9336f324e191d9775093 | 456 | Pfam | PF12872 | OST-HTH/LOTUS domain | 7 | 61 | 5.4E-8 | T | 22-09-2020 | IPR025605 | OST-HTH/LOTUS domain |
| UnnamedSample_HQ_transcript/42192|m.12310 | UnnamedSample_HQ_transcript/42192 | Identity 0.848 too low. | bcb5b3d036f49c6c7f5f36f146417ede | 325 | Pfam | PF07645 | Calcium-binding EGF domain | 141 | 170 | 3.0E-4 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/42192|m.12310 | UnnamedSample_HQ_transcript/42192 | Identity 0.848 too low. | bcb5b3d036f49c6c7f5f36f146417ede | 325 | Pfam | PF07645 | Calcium-binding EGF domain | 89 | 123 | 1.2E-5 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/42192|m.12310 | UnnamedSample_HQ_transcript/42192 | Identity 0.848 too low. | bcb5b3d036f49c6c7f5f36f146417ede | 325 | Pfam | PF02412 | Thrombospondin type 3 repeat | 269 | 304 | 1.8E-12 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/97043|m.22237 | UnnamedSample_HQ_transcript/97043 | Identity 0.841 too low. | bcb5b3d036f49c6c7f5f36f146417ede | 325 | Pfam | PF07645 | Calcium-binding EGF domain | 141 | 170 | 3.0E-4 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/97043|m.22237 | UnnamedSample_HQ_transcript/97043 | Identity 0.841 too low. | bcb5b3d036f49c6c7f5f36f146417ede | 325 | Pfam | PF07645 | Calcium-binding EGF domain | 89 | 123 | 1.2E-5 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/97043|m.22237 | UnnamedSample_HQ_transcript/97043 | Identity 0.841 too low. | bcb5b3d036f49c6c7f5f36f146417ede | 325 | Pfam | PF02412 | Thrombospondin type 3 repeat | 269 | 304 | 1.8E-12 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/82483|m.20108 | UnnamedSample_HQ_transcript/82483 | Identity 0.874 too low. | bcb5b3d036f49c6c7f5f36f146417ede | 325 | Pfam | PF07645 | Calcium-binding EGF domain | 141 | 170 | 3.0E-4 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/82483|m.20108 | UnnamedSample_HQ_transcript/82483 | Identity 0.874 too low. | bcb5b3d036f49c6c7f5f36f146417ede | 325 | Pfam | PF07645 | Calcium-binding EGF domain | 89 | 123 | 1.2E-5 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/82483|m.20108 | UnnamedSample_HQ_transcript/82483 | Identity 0.874 too low. | bcb5b3d036f49c6c7f5f36f146417ede | 325 | Pfam | PF02412 | Thrombospondin type 3 repeat | 269 | 304 | 1.8E-12 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/87312|m.20842 | UnnamedSample_HQ_transcript/87312 | Identity 0.864 too low. | bcb5b3d036f49c6c7f5f36f146417ede | 325 | Pfam | PF07645 | Calcium-binding EGF domain | 141 | 170 | 3.0E-4 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/87312|m.20842 | UnnamedSample_HQ_transcript/87312 | Identity 0.864 too low. | bcb5b3d036f49c6c7f5f36f146417ede | 325 | Pfam | PF07645 | Calcium-binding EGF domain | 89 | 123 | 1.2E-5 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/87312|m.20842 | UnnamedSample_HQ_transcript/87312 | Identity 0.864 too low. | bcb5b3d036f49c6c7f5f36f146417ede | 325 | Pfam | PF02412 | Thrombospondin type 3 repeat | 269 | 304 | 1.8E-12 | T | 22-09-2020 | IPR003367 | Thrombospondin, type 3-like repeat |
| UnnamedSample_HQ_transcript/12818|m.4762 | UnnamedSample_HQ_transcript/12818 | Coverage 0.126 too low. | 84a9ce3a0515be3f92f4d0d37e01891c | 411 | Pfam | PF16212 | Phospholipid-translocating P-type ATPase C-terminal | 147 | 394 | 5.9E-59 | T | 22-09-2020 | IPR032630 | P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/9074|m.3535 | UnnamedSample_HQ_transcript/9074 | Coverage 0.033 too low. | 064e34167d6f3487485e1b5c387fab78 | 1390 | Pfam | PF00046 | Homeodomain | 869 | 916 | 1.1E-7 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/9074|m.3535 | UnnamedSample_HQ_transcript/9074 | Coverage 0.033 too low. | 064e34167d6f3487485e1b5c387fab78 | 1390 | Pfam | PF00046 | Homeodomain | 1044 | 1088 | 2.1E-9 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/9074|m.3535 | UnnamedSample_HQ_transcript/9074 | Coverage 0.033 too low. | 064e34167d6f3487485e1b5c387fab78 | 1390 | Pfam | PF00046 | Homeodomain | 980 | 1020 | 3.2E-6 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/85271|m.20542 | UnnamedSample_HQ_transcript/85271 | Coverage 0.794 too low. | b450a4280670aff7edc72c59546e3224 | 409 | Pfam | PF00079 | Serpin (serine protease inhibitor) | 39 | 404 | 7.5E-96 | T | 22-09-2020 | IPR023796 | Serpin domain |
| UnnamedSample_HQ_transcript/110575|m.23906 | UnnamedSample_HQ_transcript/110575 | Unmapped. | 1e9fee05915807c6c168e467867e85f8 | 183 | Pfam | PF00009 | Elongation factor Tu GTP binding domain | 1 | 152 | 6.1E-39 | T | 22-09-2020 | IPR000795 | Transcription factor, GTP-binding domain |
| UnnamedSample_HQ_transcript/14326|m.5203 | UnnamedSample_HQ_transcript/14326 | Coverage 0.933 too low. | 2872bed80ebca52b50d85ff84b8f2f6c | 1185 | Pfam | PF00435 | Spectrin repeat | 527 | 627 | 2.0E-7 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/14326|m.5203 | UnnamedSample_HQ_transcript/14326 | Coverage 0.933 too low. | 2872bed80ebca52b50d85ff84b8f2f6c | 1185 | Pfam | PF00435 | Spectrin repeat | 884 | 974 | 1.1E-5 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/14326|m.5203 | UnnamedSample_HQ_transcript/14326 | Coverage 0.933 too low. | 2872bed80ebca52b50d85ff84b8f2f6c | 1185 | Pfam | PF00435 | Spectrin repeat | 633 | 702 | 1.5E-7 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/14326|m.5203 | UnnamedSample_HQ_transcript/14326 | Coverage 0.933 too low. | 2872bed80ebca52b50d85ff84b8f2f6c | 1185 | Pfam | PF00307 | Calponin homology (CH) domain | 35 | 137 | 1.2E-23 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/14326|m.5203 | UnnamedSample_HQ_transcript/14326 | Coverage 0.933 too low. | 2872bed80ebca52b50d85ff84b8f2f6c | 1185 | Pfam | PF00307 | Calponin homology (CH) domain | 151 | 254 | 1.4E-20 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/14326|m.5203 | UnnamedSample_HQ_transcript/14326 | Coverage 0.933 too low. | 2872bed80ebca52b50d85ff84b8f2f6c | 1185 | Pfam | PF17902 | SH3 domain | 701 | 766 | 7.7E-22 | T | 22-09-2020 | IPR041615 | Desmoplakin, SH3 domain |
| UnnamedSample_HQ_transcript/4892|m.2148 | UnnamedSample_HQ_transcript/4892 | Coverage 0.427 too low. | b66b12eaca4540e36750580c801f1371 | 1245 | Pfam | PF19056 | WD40 repeated domain | 867 | 1082 | 5.1E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/4892|m.2148 | UnnamedSample_HQ_transcript/4892 | Coverage 0.427 too low. | b66b12eaca4540e36750580c801f1371 | 1245 | Pfam | PF09744 | JNK_SAPK-associated protein-1 | 5 | 49 | 1.9E-7 | T | 22-09-2020 | IPR019143 | JNK/Rab-associated protein-1, N-terminal |
| UnnamedSample_HQ_transcript/4892|m.2148 | UnnamedSample_HQ_transcript/4892 | Coverage 0.427 too low. | b66b12eaca4540e36750580c801f1371 | 1245 | Pfam | PF16471 | JNK-interacting protein leucine zipper II | 243 | 312 | 6.7E-31 | T | 22-09-2020 | IPR032486 | JNK-interacting protein, leucine zipper II |
| UnnamedSample_HQ_transcript/44994|m.12911 | UnnamedSample_HQ_transcript/44994 | Coverage 0.989 too low. | 5c1df11176aab70db552c275f4bb6d47 | 692 | Pfam | PF01189 | 16S rRNA methyltransferase RsmB/F | 162 | 419 | 2.1E-38 | T | 22-09-2020 | IPR001678 | SAM-dependent methyltransferase RsmB/NOP2-type |
| UnnamedSample_HQ_transcript/54908|m.15028 | UnnamedSample_HQ_transcript/54908 | Coverage 0.712 too low. | 63a1bb48b8d895433287f4a1fb240d42 | 343 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 54 | 326 | 3.6E-91 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/28268|m.9035 | UnnamedSample_HQ_transcript/28268 | Coverage 0.062 too low. | 43617db6eac0686a1fbae1d6f3eae3a3 | 606 | Pfam | PF00531 | Death domain | 522 | 601 | 2.3E-15 | T | 22-09-2020 | IPR000488 | Death domain |
| UnnamedSample_HQ_transcript/28268|m.9035 | UnnamedSample_HQ_transcript/28268 | Coverage 0.062 too low. | 43617db6eac0686a1fbae1d6f3eae3a3 | 606 | Pfam | PF00791 | ZU5 domain | 174 | 270 | 3.0E-29 | T | 22-09-2020 | IPR000906 | ZU5 domain |
| UnnamedSample_HQ_transcript/28268|m.9035 | UnnamedSample_HQ_transcript/28268 | Coverage 0.062 too low. | 43617db6eac0686a1fbae1d6f3eae3a3 | 606 | Pfam | PF17217 | UPA domain | 329 | 469 | 3.6E-45 | T | 22-09-2020 | IPR033772 | UPA domain |
| UnnamedSample_HQ_transcript/38838|m.11586 | UnnamedSample_HQ_transcript/38838 | Coverage 0.874 too low. | adf38bee5dcd085156f4d62d440db707 | 566 | Pfam | PF00013 | KH domain | 476 | 545 | 4.3E-17 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/38838|m.11586 | UnnamedSample_HQ_transcript/38838 | Coverage 0.874 too low. | adf38bee5dcd085156f4d62d440db707 | 566 | Pfam | PF00013 | KH domain | 395 | 458 | 2.4E-14 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/38838|m.11586 | UnnamedSample_HQ_transcript/38838 | Coverage 0.874 too low. | adf38bee5dcd085156f4d62d440db707 | 566 | Pfam | PF00013 | KH domain | 146 | 215 | 1.3E-13 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/38838|m.11586 | UnnamedSample_HQ_transcript/38838 | Coverage 0.874 too low. | adf38bee5dcd085156f4d62d440db707 | 566 | Pfam | PF00013 | KH domain | 231 | 302 | 2.6E-14 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/38838|m.11586 | UnnamedSample_HQ_transcript/38838 | Coverage 0.874 too low. | adf38bee5dcd085156f4d62d440db707 | 566 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 42 | 110 | 8.8E-6 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/66170|m.17244 | UnnamedSample_HQ_transcript/66170 | Coverage 0.959 too low. | 576cfed3d9bea406153f151753493f18 | 273 | Pfam | PF02077 | SURF4 family | 10 | 273 | 3.5E-119 | T | 22-09-2020 | IPR002995 | Surfeit locus 4 |
| UnnamedSample_HQ_transcript/108636|m.23665 | UnnamedSample_HQ_transcript/108636 | Coverage 0.265 too low. | de4cf13bd949c59cfb9b30994a3286d4 | 112 | Pfam | PF00428 | 60s Acidic ribosomal protein | 22 | 111 | 6.2E-28 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/117192|m.24605 | UnnamedSample_HQ_transcript/117192 | Coverage 0.911 too low. | de4cf13bd949c59cfb9b30994a3286d4 | 112 | Pfam | PF00428 | 60s Acidic ribosomal protein | 22 | 111 | 6.2E-28 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/120413|m.24877 | UnnamedSample_HQ_transcript/120413 | Coverage 0.931 too low. | de4cf13bd949c59cfb9b30994a3286d4 | 112 | Pfam | PF00428 | 60s Acidic ribosomal protein | 22 | 111 | 6.2E-28 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/97190|m.22261 | UnnamedSample_HQ_transcript/97190 | Coverage 0.989 too low. | c46a00b54b57fd5b9b7eeb9058c4e0fa | 312 | Pfam | PF02803 | Thiolase, C-terminal domain | 166 | 305 | 5.3E-45 | T | 22-09-2020 | IPR020617 | Thiolase, C-terminal |
| UnnamedSample_HQ_transcript/97190|m.22261 | UnnamedSample_HQ_transcript/97190 | Coverage 0.989 too low. | c46a00b54b57fd5b9b7eeb9058c4e0fa | 312 | Pfam | PF00108 | Thiolase, N-terminal domain | 1 | 158 | 1.1E-37 | T | 22-09-2020 | IPR020616 | Thiolase, N-terminal |
| UnnamedSample_HQ_transcript/1042|m.648 | UnnamedSample_HQ_transcript/1042 | Coverage 0.347 too low. | eb014a6d216826f103ce4edcab9f4085 | 1793 | Pfam | PF18701 | Family of unknown function (DUF5641) | 1693 | 1786 | 3.2E-34 | T | 22-09-2020 | IPR040676 | Domain of unknown function DUF5641 |
| UnnamedSample_HQ_transcript/1042|m.648 | UnnamedSample_HQ_transcript/1042 | Coverage 0.347 too low. | eb014a6d216826f103ce4edcab9f4085 | 1793 | Pfam | PF03564 | Protein of unknown function (DUF1759) | 144 | 225 | 4.4E-7 | T | 22-09-2020 | IPR005312 | Protein of unknown function DUF1759 |
| UnnamedSample_HQ_transcript/1042|m.648 | UnnamedSample_HQ_transcript/1042 | Coverage 0.347 too low. | eb014a6d216826f103ce4edcab9f4085 | 1793 | Pfam | PF17921 | Integrase zinc binding domain | 1415 | 1466 | 1.1E-6 | T | 22-09-2020 | IPR041588 | Integrase zinc-binding domain |
| UnnamedSample_HQ_transcript/1042|m.648 | UnnamedSample_HQ_transcript/1042 | Coverage 0.347 too low. | eb014a6d216826f103ce4edcab9f4085 | 1793 | Pfam | PF05585 | Putative peptidase (DUF1758) | 485 | 633 | 6.3E-17 | T | 22-09-2020 | IPR008737 | Peptidase aspartic, putative |
| UnnamedSample_HQ_transcript/1042|m.648 | UnnamedSample_HQ_transcript/1042 | Coverage 0.347 too low. | eb014a6d216826f103ce4edcab9f4085 | 1793 | Pfam | PF05380 | Pao retrotransposon peptidase | 1002 | 1171 | 3.2E-56 | T | 22-09-2020 | IPR008042 | Retrotransposon, Pao |
| UnnamedSample_HQ_transcript/34195|m.10519 | UnnamedSample_HQ_transcript/34195 | Unmapped. | 39b48f2e671592de96acbbe5224a34f6 | 853 | Pfam | PF08762 | CRPV capsid protein like | 673 | 824 | 1.5E-9 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/68991|m.17760 | UnnamedSample_HQ_transcript/68991 | Identity 0.890 too low. | c6020a72464b3b3f4a24b7b0039423b6 | 193 | Pfam | PF16300 | Type of WD40 repeat | 1 | 38 | 1.5E-17 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8349|m.3306 | UnnamedSample_HQ_transcript/8349 | Coverage 0.042 too low. | e175098cec1b42a5e9ca59edeb1a94a9 | 500 | Pfam | PF00096 | Zinc finger, C2H2 type | 279 | 301 | 5.2E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/8349|m.3306 | UnnamedSample_HQ_transcript/8349 | Coverage 0.042 too low. | e175098cec1b42a5e9ca59edeb1a94a9 | 500 | Pfam | PF00096 | Zinc finger, C2H2 type | 335 | 357 | 8.4E-7 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/8349|m.3306 | UnnamedSample_HQ_transcript/8349 | Coverage 0.042 too low. | e175098cec1b42a5e9ca59edeb1a94a9 | 500 | Pfam | PF00096 | Zinc finger, C2H2 type | 251 | 273 | 0.0039 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/8349|m.3306 | UnnamedSample_HQ_transcript/8349 | Coverage 0.042 too low. | e175098cec1b42a5e9ca59edeb1a94a9 | 500 | Pfam | PF00096 | Zinc finger, C2H2 type | 420 | 441 | 4.4E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/8349|m.3306 | UnnamedSample_HQ_transcript/8349 | Coverage 0.042 too low. | e175098cec1b42a5e9ca59edeb1a94a9 | 500 | Pfam | PF00096 | Zinc finger, C2H2 type | 447 | 469 | 0.013 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/8349|m.3306 | UnnamedSample_HQ_transcript/8349 | Coverage 0.042 too low. | e175098cec1b42a5e9ca59edeb1a94a9 | 500 | Pfam | PF00096 | Zinc finger, C2H2 type | 363 | 385 | 9.4E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/63870|m.16817 | UnnamedSample_HQ_transcript/63870 | Coverage 0.574 too low. | 136c17cda401590330555c6dc4a87e09 | 513 | Pfam | PF02872 | 5'-nucleotidase, C-terminal domain | 247 | 425 | 1.8E-39 | T | 22-09-2020 | IPR008334 | 5'-Nucleotidase, C-terminal |
| UnnamedSample_HQ_transcript/20055|m.6886 | UnnamedSample_HQ_transcript/20055 | Coverage 0.368 too low. | 1ea4a28f2d10841c718f646512be998a | 947 | Pfam | PF00307 | Calponin homology (CH) domain | 19 | 121 | 1.2E-15 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/61170|m.16298 | UnnamedSample_HQ_transcript/61170 | Coverage 0.959 too low. | ea7a09f9345d9ddbbf1b3ff4df5c9e45 | 523 | Pfam | PF00067 | Cytochrome P450 | 36 | 507 | 4.0E-89 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/59712|m.16001 | UnnamedSample_HQ_transcript/59712 | Coverage 0.938 too low. | ea7a09f9345d9ddbbf1b3ff4df5c9e45 | 523 | Pfam | PF00067 | Cytochrome P450 | 36 | 507 | 4.0E-89 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/64690|m.16976 | UnnamedSample_HQ_transcript/64690 | Coverage 0.984 too low. | ea7a09f9345d9ddbbf1b3ff4df5c9e45 | 523 | Pfam | PF00067 | Cytochrome P450 | 36 | 507 | 4.0E-89 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/41488|m.12154 | UnnamedSample_HQ_transcript/41488 | Identity 0.772 too low. | 9f5accf8fd5e84a002c50528ed5a4980 | 666 | Pfam | PF05649 | Peptidase family M13 | 5 | 398 | 2.0E-39 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/41488|m.12154 | UnnamedSample_HQ_transcript/41488 | Identity 0.772 too low. | 9f5accf8fd5e84a002c50528ed5a4980 | 666 | Pfam | PF01431 | Peptidase family M13 | 458 | 661 | 5.3E-52 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/42497|m.12373 | UnnamedSample_HQ_transcript/42497 | Identity 0.756 too low. | 9f5accf8fd5e84a002c50528ed5a4980 | 666 | Pfam | PF05649 | Peptidase family M13 | 5 | 398 | 2.0E-39 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/42497|m.12373 | UnnamedSample_HQ_transcript/42497 | Identity 0.756 too low. | 9f5accf8fd5e84a002c50528ed5a4980 | 666 | Pfam | PF01431 | Peptidase family M13 | 458 | 661 | 5.3E-52 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/49771|m.13973 | UnnamedSample_HQ_transcript/49771 | Identity 0.746 too low. | 9f5accf8fd5e84a002c50528ed5a4980 | 666 | Pfam | PF05649 | Peptidase family M13 | 5 | 398 | 2.0E-39 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/49771|m.13973 | UnnamedSample_HQ_transcript/49771 | Identity 0.746 too low. | 9f5accf8fd5e84a002c50528ed5a4980 | 666 | Pfam | PF01431 | Peptidase family M13 | 458 | 661 | 5.3E-52 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/43273|m.12550 | UnnamedSample_HQ_transcript/43273 | Identity 0.767 too low. | 9f5accf8fd5e84a002c50528ed5a4980 | 666 | Pfam | PF05649 | Peptidase family M13 | 5 | 398 | 2.0E-39 | T | 22-09-2020 | IPR008753 | Peptidase M13, N-terminal domain |
| UnnamedSample_HQ_transcript/43273|m.12550 | UnnamedSample_HQ_transcript/43273 | Identity 0.767 too low. | 9f5accf8fd5e84a002c50528ed5a4980 | 666 | Pfam | PF01431 | Peptidase family M13 | 458 | 661 | 5.3E-52 | T | 22-09-2020 | IPR018497 | Peptidase M13, C-terminal domain |
| UnnamedSample_HQ_transcript/17218|m.6071 | UnnamedSample_HQ_transcript/17218 | Coverage 0.822 too low. | 3d06edb63af2235b4344d04b2a5ae56b | 925 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 357 | 431 | 2.2E-5 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/1631|m.906 | UnnamedSample_HQ_transcript/1631 | Identity 0.899 too low. | 8f67f8af474bce685df57edfd5f2325b | 1636 | Pfam | PF01388 | ARID/BRIGHT DNA binding domain | 277 | 364 | 3.3E-18 | T | 22-09-2020 | IPR001606 | ARID DNA-binding domain |
| UnnamedSample_HQ_transcript/1631|m.906 | UnnamedSample_HQ_transcript/1631 | Identity 0.899 too low. | 8f67f8af474bce685df57edfd5f2325b | 1636 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 1383 | 1616 | 1.9E-103 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/68579|m.17679 | UnnamedSample_HQ_transcript/68579 | Coverage 0.266 too low. | 6f706125cebbee31d14553d50c93766e | 213 | Pfam | PF13639 | Ring finger domain | 9 | 57 | 2.1E-8 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/69860|m.17906 | UnnamedSample_HQ_transcript/69860 | Coverage 0.257 too low. | 6f706125cebbee31d14553d50c93766e | 213 | Pfam | PF13639 | Ring finger domain | 9 | 57 | 2.1E-8 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/28306|m.9044 | UnnamedSample_HQ_transcript/28306 | Coverage 0.797 too low. | 3b45b578044f75533c4c678a500af761 | 665 | Pfam | PF03456 | uDENN domain | 245 | 310 | 6.4E-7 | T | 22-09-2020 | IPR005113 | uDENN domain |
| UnnamedSample_HQ_transcript/28306|m.9044 | UnnamedSample_HQ_transcript/28306 | Coverage 0.797 too low. | 3b45b578044f75533c4c678a500af761 | 665 | Pfam | PF02141 | DENN (AEX-3) domain | 321 | 510 | 3.7E-32 | T | 22-09-2020 | IPR001194 | cDENN domain |
| UnnamedSample_HQ_transcript/16023|m.5715 | UnnamedSample_HQ_transcript/16023 | Coverage 0.701 too low. | 52fc9c47eb4a333f9b045e55bdcc2364 | 283 | Pfam | PF07766 | LETM1-like protein | 1 | 184 | 1.8E-63 | T | 22-09-2020 | IPR011685 | LETM1-like |
| UnnamedSample_HQ_transcript/65751|m.17154 | UnnamedSample_HQ_transcript/65751 | Coverage 0.978 too low. | eabf627dfa57ae938a07d84606b8b2c8 | 460 | Pfam | PF02958 | Ecdysteroid kinase | 96 | 358 | 8.0E-51 | T | 22-09-2020 | IPR004119 | Ecdysteroid kinase-like |
| UnnamedSample_HQ_transcript/31182|m.9757 | UnnamedSample_HQ_transcript/31182 | Coverage 0.488 too low. | 64491cdf8f5b940d65c684f5868cb299 | 343 | Pfam | PF00250 | Forkhead domain | 88 | 170 | 4.3E-27 | T | 22-09-2020 | IPR001766 | Fork head domain |
| UnnamedSample_HQ_transcript/540|m.400 | UnnamedSample_HQ_transcript/540 | Identity 0.903 too low. | 1617a40a4d81475ec08aad0119a99ce7 | 968 | Pfam | PF12031 | SWI/SNF-like complex subunit BAF250/Osa | 645 | 902 | 1.5E-114 | T | 22-09-2020 | IPR033388 | SWI/SNF-like complex subunit BAF250, C-terminal |
| UnnamedSample_HQ_transcript/82162|m.20057 | UnnamedSample_HQ_transcript/82162 | Coverage 0.517 too low. | 2e882fb7770a844a8625c0cb08bcf7a1 | 196 | Pfam | PF00071 | Ras family | 28 | 192 | 2.1E-33 | T | 22-09-2020 | IPR001806 | Small GTPase |
| UnnamedSample_HQ_transcript/77690|m.19327 | UnnamedSample_HQ_transcript/77690 | Coverage 0.612 too low. | 82404485cd770259bfd97ec3139b24a4 | 335 | Pfam | PF13716 | Divergent CRAL/TRIO domain | 187 | 318 | 3.8E-31 | T | 22-09-2020 | IPR001251 | CRAL-TRIO lipid binding domain |
| UnnamedSample_HQ_transcript/88394|m.20999 | UnnamedSample_HQ_transcript/88394 | Coverage 0.318 too low. | f8a01aa5449272e9f747c885c7add4ca | 420 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 29 | 420 | 2.3E-51 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/14998|m.5398 | UnnamedSample_HQ_transcript/14998 | Coverage 0.572 too low. | 2f8e3453063555844e71f9c066fe76ec | 900 | Pfam | PF19056 | WD40 repeated domain | 522 | 737 | 3.0E-49 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/97136|m.22251 | UnnamedSample_HQ_transcript/97136 | Coverage 0.133 too low. | 9a5da404a7e1469ab143edd7e64e8165 | 179 | Pfam | PF01044 | Vinculin family | 10 | 177 | 1.6E-93 | T | 22-09-2020 | IPR006077 | Vinculin/alpha-catenin |
| UnnamedSample_HQ_transcript/99181|m.22518 | UnnamedSample_HQ_transcript/99181 | Identity 0.770 too low. | 9a5da404a7e1469ab143edd7e64e8165 | 179 | Pfam | PF01044 | Vinculin family | 10 | 177 | 1.6E-93 | T | 22-09-2020 | IPR006077 | Vinculin/alpha-catenin |
| UnnamedSample_HQ_transcript/50844|m.14213 | UnnamedSample_HQ_transcript/50844 | Coverage 0.560 too low. | 27e9453be7c48434892eba65a7a381d8 | 391 | Pfam | PF09820 | Predicted AAA-ATPase | 32 | 333 | 1.1E-19 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/21512|m.7285 | UnnamedSample_HQ_transcript/21512 | Coverage 0.084 too low. | 8925910e4db1c9bcafc366f46626e0eb | 875 | Pfam | PF00013 | KH domain | 575 | 636 | 1.5E-10 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/21512|m.7285 | UnnamedSample_HQ_transcript/21512 | Coverage 0.084 too low. | 8925910e4db1c9bcafc366f46626e0eb | 875 | Pfam | PF00567 | Tudor domain | 673 | 793 | 1.9E-22 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/84001|m.20339 | UnnamedSample_HQ_transcript/84001 | Coverage 0.462 too low. | 30cfd62a00bd5f6f1caecc8ac9fdb38f | 333 | Pfam | PF18100 | Phosphodiesterase 4 upstream conserved regions (UCR) | 189 | 307 | 3.7E-54 | T | 22-09-2020 | IPR040844 | Phosphodiesterase 4 upstream conserved regions (UCR) |
| UnnamedSample_HQ_transcript/122943|m.25041 | UnnamedSample_HQ_transcript/122943 | Coverage 0.977 too low. | ce7a42b1b8511fa79fc3d854d37ae047 | 134 | Pfam | PF00067 | Cytochrome P450 | 46 | 130 | 2.5E-5 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/32208|m.10004 | UnnamedSample_HQ_transcript/32208 | Coverage 0.419 too low. | 10fdd3bc9db7d9b24f7e3c76d12cc68f | 451 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 69 | 166 | 5.6E-11 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/32208|m.10004 | UnnamedSample_HQ_transcript/32208 | Coverage 0.419 too low. | 10fdd3bc9db7d9b24f7e3c76d12cc68f | 451 | Pfam | PF00372 | Hemocyanin, copper containing domain | 184 | 425 | 9.2E-45 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/35002|m.10721 | UnnamedSample_HQ_transcript/35002 | Coverage 0.109 too low. | d843bc290791d812504d43f9a3193d49 | 508 | Pfam | PF00535 | Glycosyl transferase family 2 | 67 | 250 | 6.7E-35 | T | 22-09-2020 | IPR001173 | Glycosyltransferase 2-like |
| UnnamedSample_HQ_transcript/35002|m.10721 | UnnamedSample_HQ_transcript/35002 | Coverage 0.109 too low. | d843bc290791d812504d43f9a3193d49 | 508 | Pfam | PF00652 | Ricin-type beta-trefoil lectin domain | 377 | 495 | 2.4E-27 | T | 22-09-2020 | IPR000772 | Ricin B, lectin domain |
| UnnamedSample_HQ_transcript/29255|m.9293 | UnnamedSample_HQ_transcript/29255 | Coverage 0.975 too low. | 699a26aebd1af404720cb2f9832cd58a | 534 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 40 | 527 | 2.0E-36 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/15424|m.5529 | UnnamedSample_HQ_transcript/15424 | Identity 0.911 too low. | fcc4a7222064c34d888f9f4352f4ff04 | 572 | Pfam | PF00567 | Tudor domain | 381 | 491 | 9.2E-8 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/2643|m.1294 | UnnamedSample_HQ_transcript/2643 | Coverage 0.074 too low. | 71a5290b9edee7cd14450e4064825023 | 1169 | Pfam | PF00397 | WW domain | 482 | 511 | 8.3E-10 | T | 22-09-2020 | IPR001202 | WW domain |
| UnnamedSample_HQ_transcript/2643|m.1294 | UnnamedSample_HQ_transcript/2643 | Coverage 0.074 too low. | 71a5290b9edee7cd14450e4064825023 | 1169 | Pfam | PF18436 | Helical box domain of E3 ubiquitin-protein ligase HECW1 | 577 | 639 | 2.7E-21 | T | 22-09-2020 | IPR040524 | E3 ubiquitin-protein ligase HECW1, helical box domain |
| UnnamedSample_HQ_transcript/2643|m.1294 | UnnamedSample_HQ_transcript/2643 | Coverage 0.074 too low. | 71a5290b9edee7cd14450e4064825023 | 1169 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 863 | 1168 | 2.1E-101 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/92764|m.21627 | UnnamedSample_HQ_transcript/92764 | Identity 0.949 too low. | fa79fca106c5fb07f9014a5ad679fd18 | 420 | Pfam | PF01576 | Myosin tail | 74 | 420 | 4.4E-51 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/20879|m.7115 | UnnamedSample_HQ_transcript/20879 | Coverage 0.959 too low. | 077c4ecac9b228db4628f47ba27fce4e | 558 | Pfam | PF03098 | Animal haem peroxidase | 2 | 507 | 2.1E-163 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/53248|m.14695 | UnnamedSample_HQ_transcript/53248 | Coverage 0.987 too low. | 35e347bc67d0d7431f07dbd19299f3f7 | 415 | Pfam | PF00441 | Acyl-CoA dehydrogenase, C-terminal domain | 261 | 408 | 5.1E-25 | T | 22-09-2020 | IPR009075 | Acyl-CoA dehydrogenase/oxidase C-terminal |
| UnnamedSample_HQ_transcript/53248|m.14695 | UnnamedSample_HQ_transcript/53248 | Coverage 0.987 too low. | 35e347bc67d0d7431f07dbd19299f3f7 | 415 | Pfam | PF02770 | Acyl-CoA dehydrogenase, middle domain | 156 | 249 | 5.4E-22 | T | 22-09-2020 | IPR006091 | Acyl-CoA oxidase/dehydrogenase, central domain |
| UnnamedSample_HQ_transcript/53248|m.14695 | UnnamedSample_HQ_transcript/53248 | Coverage 0.987 too low. | 35e347bc67d0d7431f07dbd19299f3f7 | 415 | Pfam | PF02771 | Acyl-CoA dehydrogenase, N-terminal domain | 71 | 152 | 5.8E-18 | T | 22-09-2020 | IPR013786 | Acyl-CoA dehydrogenase/oxidase, N-terminal |
| UnnamedSample_HQ_transcript/4731|m.2083 | UnnamedSample_HQ_transcript/4731 | Identity 0.728 too low. | e60da6d036b0ec7d4e51ff80ea0a3b64 | 1388 | Pfam | PF12057 | BCL2-associated athanogene 6 | 202 | 293 | 6.0E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
